REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 117 filers reported holding REVOLUTION MEDICINES INC in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,400,968 | +7.3% | 50,613 | +3.7% | 0.01% | +12.5% |
| Q2 2023 | $1,305,801 | +43.6% | 48,815 | +16.3% | 0.01% | +33.3% |
| Q1 2023 | $909,157 | +7.0% | 41,974 | +17.7% | 0.01% | 0.0% |
| Q4 2022 | $849,469 | +21.9% | 35,662 | +0.9% | 0.01% | +20.0% |
| Q3 2022 | $697,000 | +21.2% | 35,351 | +19.8% | 0.01% | +25.0% |
| Q2 2022 | $575,000 | -23.5% | 29,500 | +0.0% | 0.00% | 0.0% |
| Q1 2022 | $752,000 | -5.3% | 29,489 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $794,000 | -11.2% | 31,565 | -2.9% | 0.00% | -20.0% |
| Q3 2021 | $894,000 | -15.3% | 32,509 | -2.3% | 0.01% | +25.0% |
| Q2 2021 | $1,056,000 | -7.5% | 33,281 | +33.7% | 0.00% | 0.0% |
| Q1 2021 | $1,142,000 | +28.6% | 24,895 | +11.0% | 0.00% | +33.3% |
| Q4 2020 | $888,000 | +10.6% | 22,426 | -2.8% | 0.00% | -25.0% |
| Q3 2020 | $803,000 | +183.7% | 23,069 | +157.4% | 0.00% | +300.0% |
| Q2 2020 | $283,000 | +54.6% | 8,963 | +7.2% | 0.00% | 0.0% |
| Q1 2020 | $183,000 | – | 8,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |